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ABSTRACT
Background: Magnesium (Mg), green tea and rhodiola extracts have, in isolation, been shown to
possess stress and anxiety relieving effects. Green tea and rhodiola have been shown to modulate
EEG oscillatory brain activity associated with relaxation and stress perception. The combined
capacity of these ingredients to confer protective effects under conditions of acute stress has
yet to be examined. We tested the hypothesis that a combination of Mg (with B vitamins) +
green tea + rhodiola would acutely moderate the effects of stress exposure.
Methods: A double blind, randomised, placebo controlled, parallel group design was employed
(Clinicaltrials.gov:NCT03262376; 25/0817). One hundred moderately stressed adults received oral
supplementation of either (i) Mg + B vitamins + green tea + rhodiola; (ii) Mg + B vitamins +
rhodiola; (iii) Mg + B vitamins + green tea; or (iv) placebo. After supplementation participants were
exposed to the Trier Social Stress Test. The effects of the study treatments on
electroencephalogram (EEG) resting state alpha and theta, subjective state/mood, blood pressure,
heart rate variability and salivary cortisol responses after acute stress exposure were assessed.
Results: The combined treatment significantly increased EEG resting state theta (p < .02) –
considered indicative of a relaxed, alert state, attenuated subjective stress, anxiety and mood
disturbance, and heightened subjective and autonomic arousal (p < .05).
Conclusions: Mg, B vitamins, rhodiola and green tea extracts are a promising combination of
ingredients that may enhance coping capacity and offer protection from the negative effects of
stress exposure.







Stress and anxiety are distinct, yet highly comorbid,
affective states with the capacity to potentiate each
other’s negative effects. Both have profound conse-
quences for the quality of life of individuals and incur
substantial social and economic costs for society. Stress,
anxiety or depression accounted for 44% of all UK cases
of work-related ill health and 54% of working days lost
to illness in 2018/19 [1] and 74% of UK respondents
have felt ‘overwhelmed or unable to cope’ at some
point in the past year [2]. A global poll of 140 countries
found over a third had experienced stress (35%) or
worry (39%) ‘a lot of the day yesterday’ [3].
Magnesium (Mg) has long been proposed to offer
therapeutic action with evidence of mood stabilising
effects (e.g. depression [4], mania [5]). Mg is a particu-
larly relevant nutrient in the treatment of stress and
anxiety since Mg status is closely aligned with stress
levels: exposure to psychosocial stress increases Mg
excretion, resulting in Mg deficiency [6] which increases
endocrine stress reactivity [7], further depleting Mg
levels. Dietary levels of Mg intake are also modestly
inversely associated with subjective anxiety [8]. Further,
Mg supplementation can reduce anxiety-related symp-
tomology in anxiety vulnerable populations (e.g. pre-
menstrual syndrome) [9]; particularly when
administered with additional ingredients such a B vita-
mins which are also depleted by stress and associated
with stress alleviation [10,11].
Rhodiola has been consumed for centuries to allevi-
ate stress, anxiety and fatigue. Animal models
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demonstrate a significant stress-reducing capacity of
rhodiola after acute and chronic stress [12]. The
efficacy of rhodiola in the reduction of stress and anxiety
in humans has predominantly been demonstrated after
chronic intake (e.g. 14 days [13]). However, subjective
stress alleviation is evident after 3 days intake [14].
Further, acute rhodiola intake is proposed to increase
stress coping capacity. For example, acute intake
improves endurance and coping capacity under con-
dition of physical stress [15], and increases subjective
vigour when faced with a stressor [16]. Acute rhodiola
intake has also been shown to attenuate cardiovascular
responses (pulse pressure [17]) to stress.
Epidemiological studies show an association between
green tea consumption and reducedpsychological distress
[18]. Examination of the constituent nutrients of green tea
– specifically flavonoids (e.g. epigallocatechin gallate
[EGCG]) and L-theanine – have demonstrated a range
of functional benefits of acute consumption on subjective,
physiological and cognitive states under conditions of
acute stress provocation. These include increased subjec-
tive relaxation and calmness [19], improved subjective
mood [20], and attenuated subjective stress [19,21,22],
anxiety [22], cortisol [21] and heart-rate [22] responses.
Oscillatory brain activity measured by electroenceph-
alogram (EEG) is an emerging marker for assessing the
functional benefits of nutrient intake. Both green tea con-
stituents and rhodiola have been demonstrated to acutely
modulate oscillatory brain activity. Acute intake of L-
theanine increases resting alpha oscillatory power – con-
sidered to be an index of an increased relaxed state with-
out drowsiness [23,24]. Similarly, the green tea
constituent EGCG increases alpha and theta oscillatory
activity during a rested state, predominantly in the mid-
line frontal and central brain regions [19]; regions associ-
ated with a meditative, relaxed state. Acute rhodiola
intake has been shown to increase theta band oscillatory
brain activity during the viewing of emotionally stressful
stimuli [25] suggesting that rhodiola also has the capacity
moderate neural responses in a stress context.
Existing evidence of the capacity of Mg, B vitamins,
green tea and rhodiola to moderate the cascade of phys-
iological and psychological responses activated under
condition of stress creates a strong case to examine
the efficacy of these ingredients administered in combi-
nation to offer synergistic functional benefits above
those shown in isolation. The capacity of rhodiola and
green tea to acutely affect stress responses suggests the
synergistic contribution of these ingredients are most
worthy of exploration. Further, given emerging evi-
dence of the capacity of rhodiola and green tea to
acutely modulate neurophysiological processes, the
effects of the combined treatment on oscillatory EEG
activity associated with a relaxed state is of primary
interest. This randomised, placebo controlled trial
assessed the functional efficacy of Mg (combined B vita-
mins), green tea and rhodiola administered in combi-
nation to acutely moderate the effects of laboratory
stress exposure on EEG oscillatory brain activity during
the rested state. The capacity of the combined treatment
to attenuate the effects of stress exposure on subjective,
autonomic and endocrine responses was also assessed.
The fully combined treatment was compared to placebo,
and Mg (+B vitamins) combined with either rhodiola or
green tea in isolation. The combined treatment was
expected to offer greater functional benefit above and




The study conformed to a double blind, randomised,
placebo controlled, parallel group design comprising 4
treatment arms: (i) COMBINED: Mg + vitamins B6, B9,
B12 + green tea + rhodiola extract; (ii) GREEN TEA:
Mg + vitamins B6, B9, B12 + green tea; (iii) RHODIOLA:
Mg + vitamins B6, B9, B12 + rhodiola extract; (iv) PLA-
CEBO. The study design and primary and secondary
outcomes were pre-registered at Clinicaltrials.gov
(NCT03262376; August 25th 2017).
Primary outcomes
The effect of treatment on EEG alpha and theta oscil-
latory brain activity during the rested state and during
completion of attentional tasks under conditions of
stress exposure. The EEG outcomes associated with
cognitive task performance are reported separately
elsewhere (manuscript in preparation).
Secondary outcomes
The effect of treatment on subjective stress, mood,
anxiety, salivary cortisol, cardiovascular parameters
(BP, HRV), cognitive performance and attentional
event related potentials (ERPs). Cognitive performance
and ERP’s results are reported elsewhere in the cognitive
task related EEG paper (manuscript in preparation).
Participants
One hundred healthy adults (men = 36; women = 64)
were recruited from the University of Leeds campus
and local community. The final sample was selected
2 N. B. BOYLE ET AL.
from respondents completing an initial online self-
report screening questionnaire (N = 535) to confirm
the trial eligibility criteria (CONSORT diagram shown
in Figure 1). The study inclusion and exclusion criteria
are shown below:
Inclusion criteria
. Reporting moderate subjective stress levels (score of
≥13 to ≤25 on the stress subscale of the Depression
Anxiety and Stress Scale [DASS] [26])
. ≥18 to ≤50 years of age (premenopausal if female
indicated by self-reported lack of menopause symp-
toms or associated absence of period for 12 months+)
. BMI≥ 18 and ≤30 kg/m2
. Healthy (free from significant physical or psychiatric
disorders [self-report])
Exclusion criteria
. Intake of prescribed medication except
contraceptives
. Hypertension (self-report or resting blood pressure
>160/95 mmHg)
. Intake of regular nutritional supplementation
. Smoking > 5/day
. Pregnant or lactating
. Previous exposure to a laboratory stress protocol
. Night-working/shift work
. Recreational drug use
. Previous brain surgery or severe brain injury requir-
ing hospital treatment
. Any form of neurological condition (e.g. Epilepsy)
Respondents fulfilling the eligibility criteria were invited
to a face to face screening to confirm eligibility. Written
informed consent was attained from all included partici-
pants. The study was approved by The University of
Leeds School of Psychology Research Ethics Committee
(17-0235; granted October 30th 2017) and conducted
according to the principles of Good Clinical Practice
and The Declaration of Helsinki. An honorarium of
£60 was paid for completion of the study.
Treatments
Treatments were administered with water in a single
oral dose comprising one tablet and 2 capsules. Mg
(150 mg elemental) + vitamins B6 (0.7 mg), B9
(0.1 mg), B12 (0.00125 mg) were administered in a
single pressed tablet form. The B vitamin combination
was selected based on the association of these forms
with the maintenance of brain function, and impair-
ment in stress and mood related biochemistry (e.g.
homocysteine balance, serotonin and catecholamine
production) in cases of subclinical deficiency [28]. A
combined green tea/rhodiola extract formulation (Tea-
diola®; Sanofi-Aventis Groupe) was employed. For the
purposes of blinding, the manufacturer was requested
to split the formulation and the green tea (125 mg con-
taining 40% L-theanine [50 mg]) and rhodiola (222 mg)
treatments were administered in separate opaque
Figure 1. Study CONSORT diagram.
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capsules. Identical placebo equivalent forms (cellulose
crystalline) were produced for all treatments. Consump-
tion was witnessed and checked by the experimenter. All
treatments were manufactured by an affiliate of Sanofi-
Aventis Groupe.
Randomisation
The experimenter created 150 unique randomly
generated 6 digit/string ID codes (www.random.org).
Participants were sequentially allocated an ID code
by the experimenter at the face to face screening and
subsequently randomly allocated to treatment by an
independent statistician. To ensure a balanced represen-
tation of age and gender across treatment arms, eligible
participants were divided into six strata (male or female
and (i) 18–30, (ii) 31–40, or (iii) 41–50 years old). An
adaptive randomisation scheme was employed that
used the existing balance of the covariates gender and
age group across treatment arms to balance the
randomisation of subsequent participants to treatment
[29].
Blinding
Four treatment codes were generated by an independent
technician at Sanofi-Aventis. The independent statis-
tician employed the blinded treatment codes to allocate
participants to treatment arms. To ensure the exper-
imenters were blind to the treatment codes, one mem-
ber of the Leeds research team, not involved in
experimental testing, liaised with the statistician to pre-
pare the treatments for administration at the Leeds site.
These treatments were identifiable to the experimenter
only by the packing number. Treatments were adminis-
tered in identical capsule forms to ensure participants
were also blind to treatment.
The Leeds research team and statistician remained
blinded until the data were locked and primary statisti-
cal analysis completed. The treatments codes were bro-
ken to complete the a priori treatment comparisons as
per the fixed hierarchical statistical analysis approach




EEG was recorded continuously with a BioSemi Acti-
veTwo EEG system (BioSemi©, Amsterdam) from 64
electrodes at a 1024 Hz sampling rate. Four electroocu-
lograms (EOG) electrodes were used to record eye
movements and were placed lateral and dorsal to each
eye. Two EOGs were placed on the mastoids. EEG
recordings comprised two separate blocks: resting
state eyes open (290s), resting state eyes closed (290s).
Tasks were completed in sequential order in one
session.
Prior to analysis, EEG data were pre-processed in
Matlab using both EEGLAB [30] and Fieldtrip [31].
Data were initially down sampled to 512 Hz. All partici-
pants’ data were checked by eye and exceptionally bad
channels removed. Continuous data was then re-refer-
enced to the average of all 64 channels (with exception
of removed bad channels) and data destined for spectral
analysis were high-pass finite impulse response
(FIR) filtered using 1 Hz cut-off. Independent
component analysis (ICA) [32] was used to identify
eye-movement components in the data which were
subsequently removed by hand. Resting state data
were segmented into epochs between −0.1 and 1.8 s
(no baseline period).
After defining epochs a Matlab implementation of
the Fully Automated Statistical Thresholding for EEG
Artefact Rejection (FASTER [33]) was used to remove
artefacts in the data. This included (1) thresholded
interpolation of bad channels via identification of global
and local artefacts in channel data and (2) removal of
bad trials on the basis of remaining eye and muscle
movement noise and voltage spikes. Spectral power
was estimated across each epoch in the range of
2–40 Hz in 0.1 Hz steps using a Hann taper with a vari-
able time window (four cycles at each frequency). Fre-
quencies of specific interest – alpha (8–12 Hz) and
theta (4–7 Hz) – were extracted for statistical analysis.
Resting State (eyes open and closed) Alpha and theta
values were extracted from 0.6 to 1.2 s within each
epoch and averaged to give a mean resting state value.
Subjective measures
Stress and arousal checklist (SACL) [34] is a 30-item
adjective checklist measuring self-reported stress (e.g.
‘apprehensive’; possible range 18–72) and arousal (e.g.
‘stimulated’; 12–48). Responses were made on a four-
point Likert scale. The long scoring method was
employed [34] and alternative versions administered
at each time point.
The profile of mood states – short form (POMS-SF)
[35] is a 37-item adjective checklist measuring six affec-
tive mood states: Tension-anxiety (possible range 0–24),
Depression-dejection (0–32), Anger-hostility (0–28),
Vigour-activity (0–24), Fatigue-inertia (0–20), Con-
fusion-bewilderment (0–20); and Total Mood Disturb-
ance Score (TMD score [0–124] which is the sum of
all subscales minus Vigour-activity).
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Bond-lader mood scale [36] comprises 16 100 mm
visual analogue scales (VAS) of three mood scores: alert-
ness, contentedness, and calmness. The VAS are
anchored by the antonyms of specific subjective states
(e.g. drowsy/alert).
Spielberger state-trait anxiety inventory (STAI) [21].
The STAI trait subscale STAIY2 was completed at
screening to control for dispositional anxiety by includ-
ing this as a covariate in statistical analyses. The state
subscale (STAI-Y1) was administered to assess transi-
tory subjective anxiety levels during the study protocol.
Cortisol
Cortisol was determined from saliva collected using a
Salivette® device (Sarstedt, Nümbrecht, Germany). Sal-
iva was extracted from the Salivette by centrifugation
(2500 rpm, 5 min) and frozen at −20°C until assay. Sali-
vary cortisol levels were assayed by an independent lab-
oratory (Daacro’s Saliva Lab Trier, Germany) using a
high sensitivity salivary cortisol competitive immunoas-
say kit (Salimetrics, LLC, U.S.A.). After assay com-
pletion, optical density was read on a BioTeK ELx808
microplate reader at 450 nm (with correction at
490 nm). The intra- and inter-assay CVs were 3.54%
and 4.39% respectively.
Blood pressure (BP)
Systolic and diastolic BP was measured using a Space-
labs 90207 (Spacelabs Medical Inc., U.S.A.) automated
oscillometric upper arm ambulatory BP monitor
(ABPm). The monitor was worn throughout the test
protocol.
Heart rate variability (HRV)
RR interval data were recorded using a V800 Polar heart
rate monitor (HRM) with a Polar H10 chest strap
(Polar®, Stockholm, Sweden) at a sampling frequency
of 1000 Hz. HRV parameters were determined using
the Kubios HRV Premium software (Ver. 3.1.0; Kubios
Oy, Kuopio, Finland). Artefacts were detected by the
Kubios automatic correction algorithm [37] and
detrended using the smoothness priors method
([38]; λ = 500). Baseline HRV data were recorded whilst
seated. HRV data were epoched and averaged into 6
time periods (shown in relation to procedural timeline
in Figure 2): Time and frequency domain outcomes
were produced for each epoch. Low (0.04–0.15 Hz),
and high (HF, 0.15–0.4 Hz) frequency bands were cal-
culated using Fourier transformation.
Stress protocol
Acute stress was experimentally induced by The Trier
Social Stress Test (TSST). The TSST is an extensively
validated and standardised paradigm [39]. Briefly,
participants gave an extemporaneous 5-minute speech
presenting themselves as a job candidate to an unre-
sponsive, social-evaluative panel of two female confed-
erates. Upon completion of the speech, participants
completed a 5-minute mathematics subtraction task in
front of the panel.
Procedure
The study was undertaken at the Human Appetite
Research Unit (HARU), University of Leeds, UK. Test-
ing was restricted to between 1100 and 1500 h to avoid
Figure 2. Procedural timeline.
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the cortisol awakening response and ensure comparable
diurnal cortisol levels. Female participants were tested
during the luteal phase to account for variation in cor-
tisol responsivity during the menstrual cycle. Partici-
pants fasted one hour and avoided alcohol and
vigorous exercise for 24 h prior to study commence-
ment. The procedural timeline is shown in Figure 2.
Upon arrival participants were fitted with the chest
strap and HRV monitor and ABPm and seated in a test-
ing cubicle to complete baseline measures (see Figure 2).
After 15 min the allocated treatment was administered.
Participants relaxed in the cubicle for 30 min before
being taken to a separate room and introduced to the
TSST. Participants returned to the testing cubicle for a
5 min anticipation period. After TSST completion par-
ticipants were taken to the EEG laboratory for fitting
of the BioSemi ActiveTwo system. Once a clear signal
was established, participants completed two resting
EEG recordings, one eyes open and one eyes closed last-
ing five minutes each. Participants were instructed to sit
as still as possible and limit eye blinks and facial move-
ments. An attention switching task and attentional bias
task were then undertaken in sequential order. Upon
completion of tasks the EEG cap was removed and par-
ticipants were free to leave the laboratory. Instructions
for collecting ambulatory measures at 3 intervals of
2 h from the time of leaving were provided. Participants
were instructed to avoid exercise and alcohol during the
collection period. All measures were returned the fol-
lowing day.
Statistical analyses
The primary outcomes were alpha and theta oscillatory
brain activities during the rested stated. The sample size
was justified upon significant modification of EEG alpha
activity following intake of a constituent of green tea. L-
theanine has been demonstrated to induce significant
changes in EEG resting state and attentional perform-
ance related alpha power [23,40–42]. The effect sizes
of L-theanine on EEG alpha activity in these studies ran-
ged from 0.803 to 1.141 (Cohen’s d). Assuming an effect
size of 0.9, α = 0.05, and a power of 80%, it was esti-
mated that a sample of 25 participants per arm (total
sample size = 100) was required to detect an effect of
this magnitude. The primary analyses were performed
in the randomised population, defined as all random-
ised subjects who received at least one dose of the treat-
ment and for whom a reliable EEG signal could be
obtained.
All statistical analyses were performed using SAS
(Statistical Analysis System, Version 9.2; SAS Institute,
Inc., Cary, NC). Residual plots were inspected for
deviations from normality. Cortisol data were skewed
and normalised using logarithmic transformations.
One participant was removed and replaced due to a
fault in the EEG system. Eight participants’ HRV data
were removed from the ambulatory epoch due to
recorded data being less than the 6 hrs required (exclu-
sions: COMBINED: n = 2; RHODIOLA: n = 1; GREEN
TEA: n = 1; PLACEBO: n = 4). LSMeans and SEM are
presented for primary and secondary outcomes.
A mixed-effects ANCOVA was employed with treat-
ment and gender entered as fixed model effects and par-
ticipant ID entered as a random effect. For repeated
measures outcomes, values at time 1 (HRV: Baseline
epoch) were entered as a covariate in analyses to control
for baseline effects. Age, gender, BMI, trait anxiety
(STAIY2), and DASS stress score were entered as cov-
ariates in all models and removed or retained based
on the Akaike Information Criterion (AIC). To control
the family-wise type 1 error rate, a fixed sequence testing
procedure (six-steps) was used to assess the effect of
each treatment arm within each primary outcome.
The six-step sequence adhered to the following order:
(1) COMBINED vs. PLACEBO; (2) COMBINED vs.
RHODIOLA; (3) GREEN TEA vs. PLACEBO; (4) RHO-
DIOLA vs. PLACEBO; (5) COMBINED vs. GREEN
TEA; (6) RHODIOLA vs. GREEN TEA. The signifi-
cance at a level of 0.05 was tested only if the results of
the previous step reached significance. Secondary end-
points related to the secondary objectives were also
tested using the same fixed sequence procedure. For
repeated measures secondary outcomes, significant
treatment x time interactions necessitated the analysis
of outcomes by time point. If a comparison in the six-
sequence procedure reached significance at a particular
time point on an outcome, the corresponding level of
comparisons is reported for all time points on this out-
come. Exploratory (post hoc) analyses of the compari-
sons not reached in the fixed sequence due to non-
significance of previous steps are supplied as sup-
plementary materials and briefly summarised in the dis-
cussion for exploratory purposes only and to aid future
investigation of the ingredients.
For analyses of primary EEG outcomes during the
rested state two approaches were adopted. The effect
of L-theanine on resting Alpha shows diffuse activation
across multiple neural regions [23]. Therefore a whole
brain approach was employed to capture this activity.
An independent sample t-test (Monte Carlo approach
500 random permutations for all electrodes) was
employed in Fieldtrip [31] to compare oscillatory
Alpha power magnitude (µV) outcome differences
between the treatments following the six-step fixed
sequence. An a priori ROI approach was employed to
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examine resting state theta; specifically, theta activity in
the frontal midline region (comprising channels: ‘Cz’,
‘Fz’, ‘FCz’, ‘FC1’, ‘FC2’ indicated in Figure 6(A))
which is associated with a focussed, relaxed state and
anxiolytic action [43]. Power values (µV) were extracted
from these electrodes, averaged, and analysed by mixed
effect ANCOVA as per the procedure outlined above.
Results
A descriptive summary of the final sample is shown in
Table 1. One way ANOVAs revealed no significant
differences between the study treatments across the par-
ticipant characteristics of Age (F(3,96) = 2.318, p = .08),
BMI (F = <1), STAI-Y2 ([trait anxiety]; F(3,96) = 2.185,
p = .10), and DASS stress score (F = <1).
Primary outcomes
Resting state EEG
Resting alpha. No significant whole brain comparison
differences were observed in Alpha band activity
between COMBINED and PLACEBO treatments
during the eyes open and eyes closed resting state (p
>.05; spectral maps are shown in supplementary
materials). Accordingly, no further comparisons are
reported.
Resting theta. Frontal midline theta (Fmθ) ROI analysis
revealed intake of the COMBINED treatment signifi-
cantly increased theta power vs. PLACEBO, t(96) =
2.3; p = .02; Figure 3(A), and vs. RHODIOLA, t(96) =
3.44; p = .001, in the eyes open rested state (Figure 3
(B)). No significant difference in theta power was
revealed between GREEN TEA and PLACEBO treat-
ments in the eyes open rested state and between the
COMBINED and PLACEBO treatments in the eyes
closed condition (Figure 3(C)). Accordingly, no further
comparisons are reported.
Secondary outcomes
Stress and arousal checklist (SACL)
Stress: The COMBINED treatment significantly attenu-
ated subjective stress vs. PLACEBO during the recovery
period (+115 min; t(90)= −2.11; p = .04; Figure 4(A))
and by trend after stressor cessation (+65 min; t(90)=
−1.83; p = .07) and during the ambulatory period
(+245 min: t(89)= −1.74; p = .08). The COMBINED
treatment also significantly attenuated stress vs. RHO-
DIOLA across the response profile: +65 min: t(90)=
−2.01; p = .05; +100 min: t(90)= −2.47; p = .02;
+115 min: t(90)= −2.12; p = .04; +245 min: t(89)=
−2.23; p = .03; +365 min: t(88)= −2.25; p = .03; and
+485 min: t(87)= −2.23; p = .03. GREEN TEA did not
significantly differ from PLACEBO at these time points.
Accordingly, no further comparisons are reported.
Arousal: The COMBINED treatment significantly
increased subjective arousal in anticipation of stress
vs. PLACEBO (+50 min, t(91) = 2.38; p = .02; Figure 4
(B)). Heightened arousal in the COMBINED treatment
was maintained after stressor cessation vs. PLACEBO by
trend (+65 min, t(91) = 1.87; p = .06) and significantly
reactivated during the ambulatory period (+245 min, t
(90) = 2.7; p = .01). COMBINED did not significantly
differ from RHODIOLA at these time points. Accord-
ingly, no further comparisons are reported.
Profile of mood states (POMS)
POMS subscale figures are shown in Figure 5.
Tension-Anxiety: The COMBINED treatment signifi-
cantly attenuated tension-anxiety during the ambulatory
period vs. PLACEBO at +245 min (t(88)= −2.32; p = .02)
and by trend at +485 min (t(87)= −1.89; p = .06). The
COMBINED treatment also significantly attenuated ten-
sion-anxiety vs. RHODIOLA across the response profile:
+125 min: t(89)= −2.02; p = .05; +245 min: t(88)= −3.23;
p = .002; +365 min: t(88)= −2.1; p= .04; +485 min: t
(87)= −2.16; p = .03. GREEN TEA did not significantly
differ from PLACEBO at these time points. Accordingly,
no further comparisons are reported.
Depression-Dejection: The COMBINED treatment
significantly reduced depression-dejection vs. PLA-
CEBO at +245 min (t(89)= −2.86; p = .01), and vs.
RHODIOLA at +125 min (t(90)= −2.61; p = .01), and
+245 min (t(89)= −2.23; p = .03). GREEN TEA did
not significantly differ from PLACEBO at these time
points. Accordingly, no further comparisons are
reported.
Table 1. Summary characteristics of the sample receiving each treatment.
Treatment N Sex
Age BMI STAI Y2 DASS
Mean (SEM)















Placebo 25 17F 8M 25.56 (1.55) 23.69 (0.56) 43.12 (1.37) 15.96 (0.66)
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Anger-Hostility: The COMBINED treatment signifi-
cantly attenuated anger-hostility vs. PLACEBO (t(90)=
−3.05; p = .003) and RHODIOLA (t(90)= −2.7;
p = .03) at +245 min. GREEN TEA initially significantly
increased anger-hostility at +65 min (t(91) = 2.41; p
= .02), then attenuated ratings at +245 min (t(90)=
−2.44; p = .02) vs. PLACEBO. RHODIOLA did not sig-
nificantly differ from PLACEBO at this time point.
Accordingly, no further comparisons are reported.
Vigour-Activity: The COMBINED treatment signifi-
cantly increased vigour-activity vs. PLACEBO (t(91) =
2.47; p = .02) and RHODIOLA (t(91) = 2.89; p = .005)
Figure 3.Maps depicting comparison of resting state theta power by treatment (maps A, B, and C; positive values indicate COMBINED
> effect in comparison). ROI midline frontal electrodes shown by • in A. (A): t-Statistic for comparison of theta band activity for eyes
open COMBINED vs. PLACEBO; (B): and eyes open COMBINED vs. RHODIOLA; (C): t-Statistic for comparison of theta band activity for
eyes closed COMBINED vs. PLACEBO. (D): Mean averaged ROI (SEM) midline frontal theta power eyes open; (E) and closed by
treatment.
Figure 4. SACL Stress (A) and Arousal (B) response profile by treatment.
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after stressor cessation (+65 min). GREEN TEA did not
significantly differ from PLACEBO at this time point.
Accordingly, no further comparisons are reported.
Fatigue-Inertia: The COMBINED treatment signifi-
cantly attenuated fatigue-inertia vs. PLACEBO during
the ambulatory period at +245 min (t(90)= −2.33; p
= .02) and +365 min (t(90)= −1.99; p = .05). COM-
BINED did not significantly differ from RHODIOLA
at these time points. Accordingly, no further compari-
sons are reported.
Confusion-Bewilderment: No significant differences
between COMBINED vs. PLACEBO. Accordingly, no
further comparisons are reported.
Total Mood Disturbance score: The COMBINED
treatment significantly attenuated TMD score during
the ambulatory period at +245 min vs. PLACEBO (t
(89)= −3.21; p = .002) and RHODIOLA (t(89)= −2.3;
p = .02). GREEN TEA did not significantly differ from
PLACEBO at this time point. Accordingly, no further
comparisons are reported.
Figure 5. POMS subscale response profiles: (A) Tension-Anxiety; (B) Depression-Dejection; (C) Anger-Hostility; (D) Vigour-Activity;
(E) Fatigue-Inertia; (F) Total Mood Disturbance score.
Figure 6. Response profiles for: (A) Bond-Lader Alertness; (B) STAI state anxiety.
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Bond-lader mood scale
The COMBINED treatment significantly increased sub-
jective alertness vs. PLACEBO during the ambulatory
period at +245 min (t(89) = 3.05; p = .003) and
+365 min (t(90) = 2.99; p = .004; Figure 6(A)). COM-
BINED did not significantly differ from RHODIOLA
at these time points. No significant differences between
COMBINED and PLACEBO were revealed for content-
edness or calmness VAS scales. Accordingly, no further
comparisons are reported.
Spielberger state-trait anxiety inventory
(STAI – Y1)
The COMBINED treatment significantly attenuated
subjective anxiety vs. PLACEBO (t(88) =−2.43; p
= .02) and RHODIOLA (t(88)= −1.99; p = .05) during
the ambulatory period at +245 min (Figure 6(B)).
GREEN TEA did not significantly differ from PLA-
CEBO at this time point. Accordingly, no further com-
parisons are reported.
Salivary cortisol
No significant differences between COMBINED vs.
PLACEBO. Accordingly, no further comparisons are
reported. The salivary cortisol response profile is
shown in supplementary materials.
Blood pressure
The COMBINED treatment significantly raised diastolic
BP during the ambulatory period at +485 min (x =
75.03, SEM = 1.55 mmHg) vs. PLACEBO (x = 69.33,
SEM = 1.66 mmHg, t(86) = 2.52; p = .01). The COM-
BINED treatment did not significantly differ from
RHODIOLA at this time point. No significant differ-
ences between COMBINED and PLACEBO were
revealed for systolic BP response. Accordingly, no
further comparisons are reported. BP response profiles
are shown in supplementary materials.
Heart rate variability
The COMBINED treatment (x = 2.81, SEM = 0.22) sig-
nificantly raised the Low Frequency:High Frequency
ratio (LF:HF) during the recovery HRV epoch vs. PLA-
CEBO (x = 2.09, SEM = 0.22, t(91) = 2.37; p = .02). LF:
HF was also significantly raised in COMBINED vs.
RHODIOLA during the stress (x = 3.80, SEM = 0.22
vs. x = 3.00, SEM = 0.22, t(91) = 2.56; p = .01) and recov-
ery (x = 2.81, SEM = 0.22 vs. x = 1.85, SEM = 0.22, t(91)
= 3.14; p = .002) HRV epochs. GREEN TEA did not sig-
nificantly differ from PLACEBO at these time points.
No significant differences were revealed between COM-
BINED and PLACEBO treatments for Mean RR, SDNN,
Mean Heart Rate (HR), Mean SDHR or Low and High
Frequency Power (ms2). Accordingly, no further com-
parisons are reported.
Discussion
To determine the capacity of bioactive ingredients to
confer stress and anxiety relieving effects the effects of
these ingredients need to be examined under the con-
ditions of stress. Whilst the COMBINED treatment
did not significantly moderate the salivary cortisol
response or attenuate cardiovascular response to stress,
despite existing evidence of the capacity of these ingre-
dients to do so (e.g. [21,27]), elevations in both salivary
cortisol and BP across all treatments confirmed that the
TSST successfully established a stress context. Under
these conditions of acute stress the COMBINED treat-
ment demonstrated significantly superior functional
capacity across a number of primary and secondary
outcomes.
The COMBINED treatment significantly increased
Fmθ during the eyes open resting state compared to
both PLACEBO and RHODIOLA treatments. Increased
theta activity in the frontal midline region is associated
with relaxation and modulation of anxious states.
Increases in Fmθ are shown during sustained interna-
lised attention or meditation [44], controlled breathing
[45] and biofeedback [46] relaxation. Further, Fmθ acti-
vation is positively associated with level of meditation
expertise [44]. Fmθ activation is also an established
neural effect of anxiolytic pharmaceuticals – GABA-A
and 5-HT1A receptor specific anxiolytics increase Fmθ
[43] – and is associated with reduced symptomology
in clinical samples [43]. These data suggest the COM-
BINED treatment elicited a focussed and relaxed state
under conditions of stress. This effect may be reflective
of an anxiety reducing capacity of the COMBINED
treatment. Alternatively, this may also indicate a protec-
tive capacity against the impairing effect of stress since
stress is known to decrease frontal theta activity [47].
Post hoc analyses revealed GREEN TEA significantly
increased eyes open Fmθ power vs. RHODIOLA.
Further, the COMBINED treatment was not signifi-
cantly superior to GREEN TEA. This suggests a greater
contribution of green tea over rhodiola to the heigh-
tened Fmθ observed in the COMBINED treatment.
However, GREEN TEA was not superior to PLACEBO
so the combination of the ingredients appears crucial.
10 N. B. BOYLE ET AL.
Heightened resting state Fmθ in the COMBINED
treatment did not retain significance in the eyes closed
condition. Eyes closed and open resting state measures
are commonly used interchangeably or combined as a
unified measure. However, increasing evidence suggests
the two states should be considered in isolation [48].
The exteroceptive and interoceptive mental state
hypothesis [49] considers the eyes open state reflective
of attentional and visual motor activity and the eyes
closed state of imagination and multisensory activity
[48]. Therefore, the capacity of COMBINED treatment
to influence neural state may be specific to attentional
‘online’ activity and reflective of a relaxed, yet attention-
ally focussed, state.
The COMBINED treatment did not moderate resting
state alpha activity despite containing equivalent doses
of green tea constituents previously shown increase
alpha activation [23,40]. Post hoc analyses revealed no
significant effects on resting state Alpha across any
treatment comparisons. The reason for the failure to
replicate these findings is not clear. One possibility is
the stress context in which the treatments were exam-
ined; this is the only study to examine the rested state
after stress induction. Further, green tea was not given
in isolation therefore the interaction of the ingredients
may also have negated the effects previously reported.
The COMBINED treatment was efficacious in the
alleviation of subjective states associated with stress per-
ception (SACL-stress, POMS-tension-anxiety) com-
pared to PLACEBO and RHODIOLA treatments. The
COMBINED treatment also significantly reduced sub-
jective anxiety compared to PLACEBO and RHO-
DIOLA during the ambulatory period, with lower
ratings across the response profile reaching significance
at +245 min. The capacity of the COMBINED treatment
to attenuate stress perception and alleviate anxiety indi-
cates a potential to enhance coping when faced with
acute stress. Further, post hoc analyses show the super-
iority of the COMBINED treatment vs. GREEN TEA for
stress and anxiety alleviation. This suggests green tea
and rhodiola have capacity to affect subjective state
when taken together rather than in isolation.
The COMBINED treatment increased indices of
arousal consistently across a number of measures both
acutely and temporally removed from stress induction.
SACL arousal and POMS vigour rating in anticipation
of, and immediately post-stressor, were significantly
heightened in the COMBINED treatment compared to
PLACEBO. Both arousal related subscales are primarily
measures of energetic arousal exemplified by the adjec-
tives: ‘activated’, ‘vigorous’, ‘energetic’, and therefore
can be considered evidence of an invigorating or ener-
gising effect of treatment in the face of a stressful
challenge. Further, the COMBINED treatment restored
arousal levels during the ambulatory period (SACL
arousal; +245 min) compared to PLACEBO. This is sup-
ported further by significantly reduced POMS fatigue
ratings and increased attentional alertness (Bond-
Lader VAS) compared to PLACEBO across the ambu-
latory period. This demonstrates the capacity of the
COMBINED treatment to maintain subjective levels of
arousal and alertness up to 5 hrs after stress cessation
following a demanding testing session.
Post hoc analyses also indicated significantly heigh-
tened arousal in the COMBINED compared to the
GREEN TEA treatment. Further, RHODIOLA signifi-
cantly increased arousal towards the end of the response
profiles vs. PLACEBO and GREEN TEA which indicates
a potential greater contribution of rhodiola to the arousing
effects of the COMBINED treatment. However, RHO-
DIOLA and GREEN TEA were both superior to PLA-
CEBO on the Bond-Lader Alertness subscale during the
ambulatory period suggesting a contribution of both
ingredients to the superiority of the COMBINED
treatment.
Further evidence of the capacity of the COMBINED
treatment to impact arousal was shown by a significantly
increased HRV LF:HF ratio compared to PLACEBO and
RHODIOLA treatments during stress period. The LF:HF
ratio is considered to reflect sympathovagal balance, with
an increased LF:HF ratio indicative of increased auto-
nomic response. The LF:HF ratio increase is suggestive
of a heightened sympathovagal arousal state and tem-
porally corresponds with heightened subjective arousal
outcomes during stress exposure. The isolated heigh-
tened diastolic BP reading in COMBINED vs. PLACEBO
treatment 7hrs after stress cessation was not corroborated
by any alteration in the more reactive systolic BP. This
isolated finding is suggestive of a measurement artefact
resultant from participants self-collecting data at this
time point. Furthermore, the level of diastolic BP reached
in the COMBINED condition kept within the normal,
healthy diastolic BP range.
The COMBINED treatment demonstrated signifi-
cant protective effects on mood under stress conditions.
POMS depressive mood and anger ratings were both
significantly reduced in the COMBINED treatment
compared to PLACEBO and RHODIOLA towards the
end of the laboratory visit and into the ambulatory
period. This capacity to offer protection from the
effects of stress on mood in the hours after stress
exposure is further supported by significantly attenu-
ated overall mood disturbance (POMS TMD) during
the ambulatory period. Many of the enhanced subjective
mood effects in the COMBINED treatment reached sig-
nificance during the later stages of the response profiles.
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This suggests a temporal effect with the greatest func-
tional mood benefits of the COMBINED treatment
emerging up to 1 hr after stress and effects evident up
to 5 and 7 hrs after stress exposure. Post hoc analyses
showed the superiority of the COMBINED treatment
over PLACEBO and RHODIOLA in the attenuation of
POMS negative mood states was also shown vs.
GREEN TEA; particularly in the early stress recovery
period when GREEN TEA appeared to increase POMS
negative mood states. This was also evident for subjec-
tive contentedness (Bond-Lader VAS) which was sig-
nificantly heightened by the COMBINED treatment
vs. GREEN TEA immediately after stress cessation
(+65 min).
A number of potential mechanistic pathways have
been described which may account for the relationship
between the examined ingredients and observed
effects. For example, animal models show that Mg
reduces neuronal hyperexcitability by inhibiting
NMDA receptor activity and plays a pivotal role in the
function of the GABA(γ-aminobutyric acid)ergic sys-
tem [50,51]; GABA is the main inhibitory neurotrans-
mitter in the mammalian brain. Constituents of green
tea and rhodiola also influence the production and
activity of neural GABA, and additionally, serotonin,
and dopamine [12,52]. The effects of the COMBINED
treatment on subjective measures were elicited in the
absence of any consistent activation of physiological
markers of stress (e.g. cortisol, BP). This is not surpris-
ing since psychophysiological correspondence between
acute stress responses is often weak [53]. Further, evi-
dence of potential brain neurochemistry mechanistic
pathways suggest stress-reducing effect can occur via
direct routes of action rather than being the indirect
product of attenuated physiological responses.
Limitations and future directions
The establishment of baseline and post-treatment Mg, B
vitamins, and relevant green tea and rhodiola constitu-
ent levels would have provided further insight into the
observed effects. The collection of relevant biochemical
nutritional markers to assess baseline levels of sup-
plemented nutritional ingredients would have been
the gold standard approach to establish this accurately.
However, the number of assays that would be required
was prohibitive in an RCT of this size and would require
venepuncture; which itself can act as a stressor. Future
studies of the observed effects should consider recording
daily food intake prior to participation to assess any
impact of basal dietary status.
The exploratory nature of the study, and existing evi-
dence of the diverse effects of the ingredients on stress
responses, informed the choice to examine a full spec-
trum of stress response outcomes assessed via several
measures. Interest in the potential contribution of
specific individual ingredients, often neglected in the lit-
erature, also informed the administration of multiple
treatments to gain greater insight into the potential of
the combined ingredients to confer functional benefit.
However, these approaches increased the complexity
of the findings reported. Significant findings arising
from this study should be used in future examination
of these ingredients to inform more focussed hypothesis
generation and in the prioritising and planning of com-
parisons to reduce the number of outcomes and simplify
the results reported.
Conclusions
This double-blind, placebo-controlled trial examined
the capacity for a combination of ingredients shown
to have stress and anxiety reducing potential in isolation
to confer synergistic benefits when combined. In a mod-
erately stressed population, the combining of Mg and
B6, B9, B12 vitamins with selected rhodiola and green
tea extracts conferred significant functional benefits
when faced with an acute stressor compared to a pla-
cebo and the non-fully combined treatment. The com-
bined treatment promoted a relaxed, focussed state –
as indexed by EEG –, reduced stress perception, and
increased energetic arousal in anticipation and in the
immediate recovery from stress exposure. The com-
bined treatment was also superior in the attenuation
of stress perception across the later recovery profile
and up to 7 h post stress, and offered protection from
negative mood disturbance, reduced subjective anxiety,
and heightened subjective energetic arousal and alert-
ness between 2 and 7 h after stress exposure. Mg, B vita-
mins, rhodiola and green tea extracts therefore
represents a promising combination of ingredients
that may enhance coping capacity and offer protection
from the negative effects of stress exposure that is
worthy of further investigation. If confirmed, there is
a significant practical benefit of a non-pharmaceutical
method of reducing the negative impact of stress con-
sidering the associated profound detriment to the qual-
ity of life of individuals and substantial social and
economic societal costs.
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